Curiox Biosystems Co., Ltd (KOSDAQ:445680)

South Korea flag South Korea · Delayed Price · Currency is KRW
119,600
+1,300 (1.10%)
At close: Feb 27, 2026
705.39%
Market Cap 2.05T
Revenue (ttm) 4.26B
Net Income (ttm) -23.25B
Shares Out 17.12M
EPS (ttm) -1,647.26
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 65,490
Average Volume 86,881
Open 118,800
Previous Close 118,300
Day's Range 117,600 - 122,000
52-Week Range 13,200 - 133,000
Beta 3.69
RSI 55.60
Earnings Date Mar 20, 2026

About Curiox Biosystems

Curiox Biosystems Co., Ltd manufactures and sells automated equipment and consumables for cell analysis processes in South Korea. It offers C-FREE Pluto systems, including Pluto workstation, an Automated Antibody Cocktailing and Cell Staining in One Station; Pluto ALPHA, a Centrifuge-free cell washing; Pluto Code, a software script that brings Curiox’s centrifuge-free washing technology. The company offers other products & accessories, including C-FREE Gripper, C-FREE Tilter, DropArray Station, DropArray Bead Plates, MINI 1000 System, HT2100 Sy... [Read more]

Industry Surgical and Medical Instruments and Apparatus
Founded 2018
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 445680
Full Company Profile

Financial Performance

In 2024, Curiox Biosystems's revenue was 4.59 billion, a decrease of -32.41% compared to the previous year's 6.79 billion. Losses were -8.09 billion, -19.44% less than in 2023.

Financial Statements

News

There is no news available yet.